Mentions
Extended reach
Total likes
Video views
AI synopsis
The group's tone is overwhelmingly positive, emphasizing the review's importance, as seen in phrases like 'many readings and citations' and 'generating lots of attention.' Words such as 'comprehensive' and 'must-have' indicate high regard, and references to clinical trials and technological advancements reflect strong engagement and perceived impact.
Most discussions express strong agreement, praising the comprehensiveness and significance of the review on nanoparticles in clinical applications.
Posts demonstrate high interest, with many highlighting the relevance of recent advancements and ongoing clinical trials.
While many comments are supportive and contain references to specific technological aspects, few provide deep analysis, indicating moderate engagement.
The frequent mention of citations, clinical trials, and the potential for future research suggests that these discussions recognize the publication’s substantial influence on the field.
I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP_UNC and @SMitragotri @Harvard I predict many readings and many, many citations. It must have been a lot of work to compile it. https://t.co/rS7K1PItEK https://t.co/EEZGYFJOi5
Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out https://t.co/wqABdRyof8 @BioTM_Buzz @ChEnected Remembering an awesome ‘Stars Collide’ session from @CRSScience in Valencia on this topic #seeyouinVegas2020 https://t.co/SgasPCxTKU
Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/IwpC7ZVR8R https://t.co/V0kJIgoKVM
Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharmacy https://t.co/SX0a5oe9sk https://t.co/Jhu7iOwLfR
Great review by @Aaron_Anselmo and @SMitragotri about Nanoparticles in the clinic: An update post COVID‐19 vaccines https://t.co/KdzhjGgQ8p #nanoparticles #nanomedicine #nanotechnology https://t.co/uABbLUwfTq
The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. https://t.co/Z8RqJtqnDA #nanoparticles #nanomedicine
Vaccines for COVID19 explores your top questions. We explain the medical scientific evidence in plain terms, including how vaccines work and their safety profiles, with animations.
Nanoparticle drug delivery systems have been in clinical use since the early 1990s and have evolved to enhance therapeutic delivery methods. Recent advancements include new generations of nanoparticles now in clinical…
Nanoparticle drug delivery systems have been in clinical use since the 1990s, evolving to improve therapeutic methods. Recent advances include new nanoparticle generations with additional functions, currently in…
Nanoparticle drug delivery systems have been in clinical use since the early 1990s and have evolved to enhance therapeutic delivery methods. This update reviews recent progress, new approved drugs, clinical trials, and…
Nanoparticle drug delivery systems have been used clinically since the 1990s. Recent advances include new generations of nanoparticles with enhanced functions, ongoing clinical trials, and new drug approvals. This…
Nanoparticle drug delivery systems have been in clinical use since the early 1990s. Recent advancements include new generations of nanoparticles with enhanced functions, many now in clinical trials or approved for…
Nanoparticle drug delivery systems have been in clinical use since the early 1990s and have evolved to enhance therapeutic delivery methods. This update reviews progress in nanomedicine over the past three years…
Nanoparticle drug delivery systems have been in clinical use since the early 1990s and have evolved to enhance therapeutic delivery methods. Recent updates include new drugs, clinical trials, and emerging nanomedicine…
Nanoparticle drug delivery systems have evolved significantly since the 1990s, with new generations emerging for enhanced therapy. This update reviews recent progress, including approved drugs, clinical trials, and…
Nanoparticle drug delivery systems have been used since the 1990s, evolving to improve therapeutic methods. Recent developments include new nanoparticle generations with additional functions, now in trials or approved…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @rubic3n: Link LNP SPION et al 2021 August Nanoparticles in the clinic: An update post COVID-19 vaccines https://t.co/tXRJdt8RfO .
Link LNP SPION et al 2021 August Nanoparticles in the clinic: An update post COVID-19 vaccines https://t.co/tXRJdt8RfO .
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
RT @JCRnEDITORS: Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/Iw…
RT @NPeppas: I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP…
I cannot say enough about the paper on "Nanoparticles in the clinic: An update post COVID-19 vaccines" by @Aaron_Anselmo @DPMP_UNC and @SMitragotri @Harvard I predict many readings and many, many citations. It must have been a lot of work to compile it. https://t.co/rS7K1PItEK https://t.co/EEZGYFJOi5
Nanoparticles in the clinic: An update post COVID‐19 vaccines. | Bioengineering & Translational Medicine | https://t.co/IwpC7ZVR8R https://t.co/V0kJIgoKVM
RT @NanomedicineLab: WE reading
RT @DPMP_UNC: Check out the updated review in @BioTM_Buzz from @Aaron_Anselmo and @SMitragotri “Nanoparticles in the clinic: An update pos…
Check out the updated review in @BioTM_Buzz from @Aaron_Anselmo and @SMitragotri “Nanoparticles in the clinic: An update post COVID-19 vaccines” @UNCPharmacy https://t.co/y8kwWkwh9n https://t.co/DAEEzTTKz9
WE reading
Great review by @Aaron_Anselmo and @SMitragotri about Nanoparticles in the clinic: An update post COVID‐19 vaccines https://t.co/KdzhjGgQ8p #nanoparticles #nanomedicine #nanotechnology https://t.co/uABbLUwfTq
@Thanatos_Letum Für die Stoffklasse der LNPs (der Nanopartikel) gibt es auch Erfahrungen von mittlerweile fast 100 klinischen Studien. Von LNP-RNA Arzneimitteln gibt es Daten von mittlerweile bis zu 3 Jahren. https://t.co/NsWgt71f0R https://t.co/XLS2gg85YX
@noone_toona @HelenTrailer @Jimmyjude13 https://t.co/O7JgqJxQP2
Nanoparticles in the clinic: An update https://t.co/bqqwJ4xY9R
@M_Wojasinski @TheChanLab 3. Nanoparticles in the clinic: An update by @SMitragotri https://t.co/qebnGISwiJ 3/3
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
RT @DPMP_UNC: Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharma…
Great comprehensive review from @Aaron_Anselmo & @SMitragotri "Nanoparticles in the clinic: An update." @ChEnected @UNCPharmacy https://t.co/SX0a5oe9sk https://t.co/Jhu7iOwLfR
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. http…
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" by @SMitragotri and @Aaron_Anselmo Is Generating Lots of Att…
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" by @SMitragotri and @Aaron_Anselmo Is Generating Lots of Att…
The new #BioTM article "Nanoparticles in the Clinic: An Update" by @SMitragotri and @Aaron_Anselmo Is Generating Lots of Attention. Check it out for FREE. https://t.co/Z8RqJtHZ2a
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. http…
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. http…
An update on nanoparticles in clinic by @Aaron_Anselmo and @SMitragotri. This answers a lots of questions of a lot of people interested in the field of nanomedicine and it’s future. https://t.co/1kkRp1pQMw
RT @ChEnected: The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. http…
The new #BioTM article "Nanoparticles in the Clinic: An Update" Is Generating Lots of Attention. Check it out for FREE. https://t.co/Z8RqJtqnDA #nanoparticles #nanomedicine
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
RT @SMitragotri: Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out…
Want to see a summary of latest clinical trials and approved products for systemically delivered nanoparticles? Check out https://t.co/wqABdRyof8 @BioTM_Buzz @ChEnected Remembering an awesome ‘Stars Collide’ session from @CRSScience in Valencia on this topic #seeyouinVegas2020 https://t.co/SgasPCxTKU